rs149051060
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_014467.3(SRPX2):c.1030C>A(p.Leu344Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000259 in 1,209,692 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 91 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., 40 hem., cov: 24)
Exomes 𝑓: 0.00015 ( 0 hom. 51 hem. )
Consequence
SRPX2
NM_014467.3 missense
NM_014467.3 missense
Scores
3
4
10
Clinical Significance
Conservation
PhyloP100: 5.66
Genes affected
SRPX2 (HGNC:30668): (sushi repeat containing protein X-linked 2) This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and cognitive disability. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.01242426).
BS2
High Hemizygotes in GnomAd4 at 40 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX2 | NM_014467.3 | c.1030C>A | p.Leu344Ile | missense_variant | 9/11 | ENST00000373004.5 | NP_055282.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX2 | ENST00000373004.5 | c.1030C>A | p.Leu344Ile | missense_variant | 9/11 | 1 | NM_014467.3 | ENSP00000362095 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 145AN: 111925Hom.: 0 Cov.: 24 AF XY: 0.00117 AC XY: 40AN XY: 34093
GnomAD3 genomes
AF:
AC:
145
AN:
111925
Hom.:
Cov.:
24
AF XY:
AC XY:
40
AN XY:
34093
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000343 AC: 63AN: 183472Hom.: 0 AF XY: 0.000265 AC XY: 18AN XY: 67914
GnomAD3 exomes
AF:
AC:
63
AN:
183472
Hom.:
AF XY:
AC XY:
18
AN XY:
67914
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000153 AC: 168AN: 1097714Hom.: 0 Cov.: 31 AF XY: 0.000140 AC XY: 51AN XY: 363074
GnomAD4 exome
AF:
AC:
168
AN:
1097714
Hom.:
Cov.:
31
AF XY:
AC XY:
51
AN XY:
363074
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00129 AC: 145AN: 111978Hom.: 0 Cov.: 24 AF XY: 0.00117 AC XY: 40AN XY: 34156
GnomAD4 genome
AF:
AC:
145
AN:
111978
Hom.:
Cov.:
24
AF XY:
AC XY:
40
AN XY:
34156
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
19
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
43
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked Pathogenic:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 31, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 03, 2017 | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 16, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 03, 2014 | p.Leu344Ile (CTC>ATC): c.1030 C>A in exon 9 in the SRPX2 gene (NM_014467.2). The L344I variant in the SRPX2 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The L344I variant has been identified at low frequency in African Americans (0.49%, 19/3835 alleles) by the NHLBI Exome Sequencing Project and was not observed in the homozygous state in any individual within this population. The L344I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret L344I as a variant of unknown significance. The variant is found in CHILD-EPI,EPILEPSY panel(s). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 08, 2018 | - - |
SRPX2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 11, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Pathogenic
D;.
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at